Explore Teva Waterford

Teva is the second largest global supplier of medicines on the World Health Organization’s (WHO) Essential Medicines List for respiratory conditions.01

Our product range includes several innovative branded medicines that treat respiratory conditions such as asthma, cystic fibrosis, and Chronic Obstructive Pulmonary Disease (COPD). Plus, we have on-going clinical trials for product candidates in our respiratory product pipeline.  

We are excited to be shaping the future of respiratory care

We are developing innovative improvements in inhaler technology; including digital advancements and e-connected devices. 

Teva's Waterford facility is recognised as a global leader for the manufacture and development of respiratory products. Our research and development focus is dedicated to the next generation respiratory products for the treatment of respiratory conditions that have a significant impact on a patient's quality of life. 

Our research covers breath-activated inhaled therapies for asthma and COPD, where incorrect inhaler technique and non-adherence have been shown to be associated with poor asthma control. 

We are also researching targeted biologics for uncontrolled asthma. 

A key area our global research teams are focusing on is e-connectivity. Using smart inhaler technology patients may be more empowered to manage their condition more effectively, and healthcare professionals could obtain greater insight into the patient's experience and condition to make more informed treatment decisions. 

We’re exploring how inhalers connect to a software programme which synchronises and stores data, and presents it through an app-based user interface. This gives both patients and clinicians a clear view of the symptoms and how their treatment could be modified, if necessary. 

For healthcare providers, greater insights could improve co-ordination of care delivery, to optimise resource allocation, and reduce costs. 

Teva Waterford is an integral part of Teva Global Operations (TGO). Since 1985 we have been manufacturing pharmaceutical products and now we make a wide range of inhalation devices on site.

Our products are highly complex and we're proud of our technical capabilities which enable us to manufacture combination products through highly automated processes. 

Our vision is to become the most innovative, most trusted, and most efficient supplier of respiratory products in the industry, improving the health of respiratory patients.

The laboratory facilities in Waterford are state-of-the-art with more than $40M invested in capabilities over the last 7 years.

Waterford scientists routinely use cutting-edge materials characterisation techniques, analyse pharmaceutical performance with ground-breaking automation techniques, manufacture material for clinical trial evaluation in pilot facilities and develop combination product devices to deliver essential medication.

We’re proud that the Waterford site’s quality standards are recognised both as the gold standard within Teva, and also by the HPRA (Health Products Regulatory Agency) and US Food and Drug Administration (FDA).

We ensure that each and every one of our inhalers meets our high quality standards, at every step in the process. We consistently validate our equipment and manufacture our products according to the most stringent global and local regulations.

As a global company with a vast network of career opportunities, we encourage our people to seek out opportunities for development – promotions, secondments, and collaborative project working – whether that’s in Ireland or further afield.

We offer extensive further education funding and support, including 100% payment of fees, along with paid study and exam leave.

We also provide a wide range of internal learning and development resources to support your growth and career progression, including a range of onsite and online offerings, training events, mentoring, and bespoke learning programmes.

Teva plays an active role in the academic community. The site recently partnered with the Waterford's South East Technological University to offer the Philip Kelly Teva Excellence Scholarship. Funded by Teva, it’s worth €9,000 and aims to support an excellent undergraduate student during their studies. 

This partnership is highly valued by Dr Helen Fox, Lecturer in Pharmaceutical Science at the Department of Science: “[Teva’s] commitment to the students at  [SETU] has had a hugely positive impact, as apart from the funding they receive, students benefit greatly from the mentorship and leadership given by strong Teva role models.” 

As the General Manager of Teva's Waterford site, he loves the challenge of leading a complex manufacturing and R&D site together. 

He is driven by a deep-rooted desire to improve the lives of patients: “Sadly, a lot of people still die every year from asthma attacks or due to long-term respiratory disease and our medicines are critical in helping patients live longer and healthier lives.”  

As a leader of hundreds of highly qualified professionals, Andy is a strong advocate for continued professional development. He encourages his teams to take up opportunities for academic and vocational education at all levels, for all roles.

Julian recommends Teva as a great place to work: “If you’re eager, ambitious, interested in science, innovative and creative then we can open so many doors for you, whether it’s focusing on a commercial role, project management or developing your scientific skills.” 

“At Waterford, we have the capability and the mindset to take on any challenge. Our R&D division shares the same site as manufacturing operations, which means we are a fully integrated business that can develop a concept, make the final product, and bring it to market. This brings so many benefits for collaboration and partnership.”

That covers the environment, access to medicines, compliance and ethics, and supply chain.

We’re minimising our impact on the planet:

• Since 2019, Teva has reduced scope 1 and 2 Green House Gases (GHG) emissions by 13%, more than half of the 2025 target.
• Globally, we've increased total proportion of energy from renewable sources to 33%
• Locally, in Waterford 100% of our energy use is drawn from green renewable energy sources.
• We're committed to a zero-waste-to-landfill policy as part of our waste management programme.

Our labs are certified by My Green Lab®: the worldwide standard for laboratory sustainability best practices.

Our local “Greensteps” sustainability programme encourages employees to submit ideas for improvements:

• Our Waterford team replaced single-use batteries with rechargeable ones across the site, as well as set up a battery recharging station.
• A cross-functional team was also set up to extend the expiry date of lower case assembly parts of inhaler devices, which ultimately avoided the disposal of 460,000 units.
• Green space biodiversity areas were created with a recreational walkway.
• A cycle-to-work scheme is available, along with secure bike storage units.

Inclusion and diversity are not just buzz words, they are key to our business and part of our commitment to society at large. We can see that in Teva diversity drives innovation and creativity and we welcome it.  

We’re proud that our most recent survey of employees based at Waterford found that 86% of our workforce feel they are treated with respect as an individual, and 78% of our employees agree that Teva culture promotes inclusion and diversity. 

We foster an inclusive work environment that allows all people to express themselves and realise their full potential. We address gender gaps and support recruitment, development and retention of individuals with diverse backgrounds - learn more in our global Environmental, Social and Governance Progress Report. 

Teva aims to be a strong ally to the LGBTQ+ community, proudly celebrating Pride - not just in June as Pride month is celebrated, but the whole year-round. Learn about some of the ways we support the LGBTQ+ community through resource groups, inclusive benefits, and more.

And if all of that wasn’t enough! The city of Waterford was officially named the 'Best Place To Live in Ireland' by the Irish Times in 2021.  

The judges’ decision was unanimous: Waterford was recognised for its historic city centre, thriving culture and beautiful location on the east coast of Ireland. 

It beat stiff competition from four other shortlisted locations: Clonakilty, Co Cork; Galway city; Glaslough, Co Monaghan; and Killarney, Co Kerry. To see which factors swung it for Waterford read the Irish Times article and maybe consider if it would have received your vote?

Teva offers you the chance to make a real difference in people's lives and drive forward your career.

Bring your energy, talent and commitment, and we’ll help you grow as an individual whilst making a positive difference to respiratory health and patients all around the world. 

If you like what you’ve seen so far, we’d love to hear from you. Search our job openings on careers.teva and find where you could fit in.